Peer-reviewedCC BY 4.0Journal of Hospital Medicine
Old disease, new twist
7 affiliations
- 1Department of Medicine University of California, San Francisco San Francisco California USA
- 2Division of Hospital Medicine University of California, San Francisco San Francisco California USA
- 3San Francisco Veterans Affairs Medical Center San Francisco California USA
- 4Division of Hospital Medicine Oregon Health and Science University Portland Oregon USA
- 5Division of Cardiology University of California, San Francisco San Francisco California USA
- 6Division of Hematology/Oncology University of California, San Francisco San Francisco California USA
- 7UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California USA
Abstract
An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of levofloxacin for possible epididymitis based on scrotal pain and an ultrasound showing mild bilateral epididymal prominence. Blood and urine cultures were negative. His constitutional symptoms persisted, and he developed a subjective fever 2 weeks prior to presentation. He was admitted for further evaluation.
Related
- A rare twist after Ex-vivo RIRS: graft parenchymal urine leak in a living donor kidney
- Advancing Genomic Surveillance of Human Parainfluenza Viruses in Côte d'Ivoire Using Twist Hybrid‐Capture Sequencing
- Higher risk, lower recurrence: A year of risk-adapted twist-drill craniostomy with pressure-controlled fibrinolytic irrigation therapy for chronic subdural hematoma.
- Curcumin carried by polystyrene nanoparticles inhibits phosphatidylinositol 3-kinase/protein kinase B signaling pathway through miR-186 and down-regulates Twist to inhibit the epithelial-mesenchymal transition in colorectal cancer in mice
- Heart Disease and Cerebrovascular Disease Mortality Trends, 2015–2025
BibTeX
@article{roudsari2026disease,
title = {{Old disease, new twist}},
author = {Hadi Roudsari and Gurpreet Dhaliwal and Anand D. Jagannath and Alan H. Baik and Sam Brondfield},
journal = {Journal of Hospital Medicine},
year = {2026},
month = sep,
doi = {10.1002/jhm.70442},
url = {https://doi.org/10.1002/jhm.70442},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Old disease, new twist
AU - Hadi Roudsari
AU - Gurpreet Dhaliwal
AU - Anand D. Jagannath
AU - Alan H. Baik
AU - Sam Brondfield
PY - 2026
DA - 2026/09/28
JO - Journal of Hospital Medicine
DO - 10.1002/jhm.70442
UR - https://doi.org/10.1002/jhm.70442
AB - An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of levofloxacin for possible epididymitis based on scrotal pain and an ultrasound showing mild bilateral epididymal prominence. Blood and urine cultures were negative. His constitutional symptoms persisted, and he developed a subjective fever 2 weeks prior to presentation. He was admitted for further evaluation.
SN - 1553-5592
SN - 1553-5606
ER -